Advanced search
Publication Cover
Journal of Asthma and Allergy Volume 14, 2021 - Issue
Submit an article Journal homepage
383
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Short-Term Subcutaneous Allergy Immunotherapy and Dupilumab are Well Tolerated in Allergic Rhinitis: A Randomized Trial

Jonathan Corren1 Departments of Medicine and Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, CA, USACorrespondence[email protected]
View further author information
,
Sarbjit S Saini2 Department of Internal Medicine, Division of Allergy and Clinical Immunology, Johns Hopkins Asthma and Allergy Center, Baltimore, MD, USAORCID Iconhttps://orcid.org/0000-0001-8522-2742View further author information
ORCID Icon,
Remi Gagnon3 Clinique Spécialisée en Allergie de la Capitale, Québec, QC, CanadaView further author information
,
Mark H Moss4 Departments of Medicine and Pediatrics, Division of Allergy, Pulmonary and Critical Care, University of Wisconsin School of Medicine and Public Health, Madison, WI, USAView further author information
,
Gordon Sussman5 Department of Medicine, University of Toronto, Toronto, ON, CanadaView further author information
,
Joshua Jacobs6 Allergy and Asthma Clinical Research, Inc, Walnut Creek, CA, USAView further author information
,
Elizabeth Laws7 Sanofi, Bridgewater, NJ, USAView further author information
,
Elinore S Chung8 Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USAView further author information
,
Tatiana Constant8 Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USAORCID Iconhttps://orcid.org/0000-0001-8619-8131View further author information
ORCID Icon,
Yiping Sun8 Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USAView further author information
,
Jennifer Maloney8 Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USAView further author information
,
Jennifer D Hamilton8 Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USAView further author information
,
Marcella Ruddy8 Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USAView further author information
,
Claire Q Wang8 Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USAView further author information
&
Meagan P O’Brien8 Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USACorrespondence[email protected]
View further author information
 show all
Pages 1045-1063 | Published online: 16 Aug 2021

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Désirée Larenas-Linnemann & Blanca María Morfin Maciel. (2023) How can we improve our use of allergen immunotherapy as a treatment option for asthma and severe asthma?. Expert Review of Respiratory Medicine 0:0, pages 1-9.
Read now

Articles from other publishers (11)

Stephen R. Durham & Mohamed H. Shamji. (2022) Allergen immunotherapy: past, present and future. Nature Reviews Immunology 23:5, pages 317-328.
Crossref
Yuxi Lin, Weiqing Wang, Zhenzhen Zhu, Surita Aodeng, Lei Wang, Yuzhuo Liu, Jingjing Li, Yang Zha, Xiaowei Wang & Wei Lv. (2023) Adverse Events for Monoclonal Antibodies in Patients with Allergic Rhinitis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Journal of Clinical Medicine 12:8, pages 2848.
Crossref
Sarah K. Wise, Cecelia Damask, Lauren T. Roland, Charles Ebert, Joshua M. Levy, Sandra Lin, Amber Luong, Kenneth Rodriguez, Ahmad R. Sedaghat, Elina Toskala, Jennifer Villwock, Baharudin Abdullah, Cezmi Akdis, Jeremiah A. Alt, Ignacio J. Ansotegui, Antoine Azar, Fuad Baroody, Michael S. Benninger, Jonathan Bernstein, Christopher Brook, Raewyn Campbell, Thomas Casale, Mohamad Chaaban, Fook Tim Chew, Jeffrey Chambliss, Antonella Cianferoni, Adnan Custovic, Elizabeth Mahoney Davis, John M. DelGaudio, Anne K. Ellis, Carrie Flanagan, Wytske J. Fokkens, Christine Franzese, Matthew Greenhawt, Amarbir Gill, Ashleigh Halderman, Jens M. Hohlfeld, Cristoforo Incorvaia, Stephanie A. Joe, Shyam Joshi, Merin Elizabeth Kuruvilla, Jean Kim, Adam M. Klein, Helene J. Krouse, Edward C. Kuan, David Lang, Desiree Larenas‐Linnemann, Adrienne M. Laury, Matt Lechner, Stella E. Lee, Victoria S. Lee, Patricia Loftus, Sonya Marcus, Haidy Marzouk, Jose Mattos, Edward McCoul, Erik Melen, James W. Mims, Joaquim Mullol, Jayakar V. Nayak, John Oppenheimer, Richard R. Orlandi, Katie Phillips, Michael Platt, Murugappan RamanathanJrJr, Mallory Raymond, Chae‐Seo Rhee, Sietze Reitsma, Matthew Ryan, Joaquin Sastre, Rodney J. Schlosser, Theodore A. Schuman, Marcus S. Shaker, Aziz Sheikh, Kristine A. Smith, Michael B. Soyka, Masayoshi Takashima, Monica Tang, Pongsakorn Tantilipikorn, Malcolm B. Taw, Jody Tversky, Matthew A. Tyler, Maria C. Veling, Dana Wallace, De Yun Wang, Andrew White & Luo Zhang. (2023) International consensus statement on allergy and rhinology: Allergic rhinitis – 2023. International Forum of Allergy & Rhinology 13:4, pages 293-859.
Crossref
Nicholas James Campion, Anna Doralt, Christian Lupinek, Markus Berger, Katharina Poglitsch, Jonas Brugger, Tamara Quint, Katharina Gangl, Christoph Sinz, Tina Bartosik, David Tianxiang Liu, Lukas David Landegger, Aldine Tu, Victoria Stanek, Uwe Berger, Christine Bangert, Sven Schneider & Julia Eckl‐Dorna. (2023) Dupilumab reduces symptom burden in allergic rhinitis and suppresses allergen‐specific IgE production . Allergy.
Crossref
David Grimm, Peter H. Hwang & Yi-Tsen Lin. (2023) The link between allergic rhinitis and chronic rhinosinusitis. Current Opinion in Otolaryngology & Head & Neck Surgery 31:1, pages 3-10.
Crossref
Tolly E.G. Epstein & Christopher W. Calabria. (2022) Is immunotherapy safe for treatment of severe asthma. Current Opinion in Allergy & Clinical Immunology 22:6, pages 396-401.
Crossref
Lorenzo Salvati, Francesco Liotta, Francesco Annunziato & Lorenzo Cosmi. (2022) Therapeutical Targets in Allergic Inflammation. Biomedicines 10:11, pages 2874.
Crossref
Yuan Zhang, Feng Lan & Luo Zhang. (2022) Update on pathomechanisms and treatments in allergic rhinitis. Allergy 77:11, pages 3309-3319.
Crossref
Amanda Atanasio, Jamie M. Orengo, Matthew A. Sleeman & Neil Stahl. (2022) Biologics as novel therapeutics for the treatment of allergy: Challenges and opportunities. Frontiers in Allergy 3.
Crossref
Yang Liu & Zheng Liu. (2022) Epidemiology, Prevention and Clinical Treatment of Allergic Rhinitis: More Understanding, Better Patient Care. Journal of Clinical Medicine 11:20, pages 6062.
Crossref
Mohamed A. Kamal, Yoko Franchetti, Ching‐Ha Lai, Christine Xu, Claire Q. Wang, Allen R. Radin, Meagan P. O'Brien, Marcella Ruddy & John D. Davis. (2022) Pharmacokinetics and Concentration‐Response of Dupilumab in Patients With Seasonal Allergic Rhinitis. The Journal of Clinical Pharmacology 62:5, pages 689-695.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.